Abalos Therapeutics’ ABX-001 Validated in Cell Reports Medicine
October 14, 2025 | Düsseldorf, Germany — Abalos Therapeutics announced the publication of preclinical proof-of-concept data in Cell Reports...
oncology research
Advertisement
Anixa Biosciences Completes Final Patient Visit in Breast Cancer Vaccine Trial
SAN JOSE, Calif., October 7, 2025 – Anixa Biosciences, Inc. (NASDAQ: ANIX), a clinical-stage biotechnology company dedicated to cancer...
Eisai Highlights Groundbreaking Oncology Data at ESMO 2025 Congress
NUTLEY, N.J., Oct. 2, 2025 — Eisai Inc. announced today the presentation of its expansive oncology portfolio at the...
First Patient Dosed in CAR-T Trial Using Synecta T1 Nanoparticles
PHILADELPHIA, September 3, 2025 — The first patient has been dosed in a clinical trial evaluating Synecta™ T1 cell-derived...
Hoth Therapeutics Advances HT-KIT After Preclinical Breakthrough
NEW YORK, Sept. 2, 2025 – Hoth Therapeutics, Inc. (NASDAQ: HOTH), a clinical-stage biopharmaceutical innovator, announced encouraging preclinical results...
Advertisement
